Filing Flows › Ceribell (CBLL) › Q3 2026 › vs Q2 2026
Ceribell (CBLL) Q3 2026 vs Q2 2026 (quarter over quarter)
Ceribell's revenue rose $1.2M (+4%) from $28.1M in Q2 2026 to $29.3M in Q3 2026. The biggest changes: Product +$994K (+5%); Subscription +$250K (+4%).
Ceribell, Q3 2026: revenue $29.3M (+30% year over year), operating margin -70.0%, net loss $21.4M, operating cash flow −$13.1M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Product | $22.2M | $21.2M | $994K | +5% |
| Subscription | $7.1M | $6.9M | $250K | +4% |
| Revenue | $29.3M | $28.1M | $1.2M | +4% |
| Net loss | $21.4M | $19.3M | $2.1M | +11% |
| Costs & expenses | $50.7M | $48.1M | $2.6M | +5% |
| Operating costs | $49.9M | $48.1M | $1.8M | +4% |
| Interest & other, net | $803K | −$713K | $1.5M | — |
| Cost of revenue | $3.0M | $2.2M | $842K | +39% |
| Research & development | $7.4M | $6.7M | $656K | +10% |
| Sales & marketing | $25.0M | $24.4M | $617K | +3% |
| General & admin | $14.5M | $14.8M | −$304K | -2% |
| Operating cash sources | $21.4M | $19.3M | $2.1M | +11% |
| Depreciation & amortization | $249K | $245K | $4K | +2% |
| Share-based compensation | $7.1M | $6.0M | $1.1M | +18% |
| Working capital & other | $926K | $162K | $764K | +472% |
| Cash used in operations | $13.1M | $12.9M | $215K | +2% |
| Net loss absorbed | $21.4M | $19.3M | $2.1M | +11% |
Questions
How much did Ceribell's revenue grow quarter over quarter in Q3 2026?
Ceribell's revenue rose $1.2M (+4%) from $28.1M in Q2 2026 to $29.3M in Q3 2026.
What drove Ceribell's revenue change in Q3 2026?
Product +$994K (+5%); Subscription +$250K (+4%).